Zenabis CEO Andrew Grieve says having the 255,000-square-foot facility in operation not only will allow the company to produce more, but also allow more flexibility to how it disperses its resources across its two other plants, one in New Brunswick and the other in Langley, B.C.

“We actually have a 255,000-square-foot facility that we can use for a variety of different components of our business, whether that’s processing and packaging, manufacturing, or a range of other activities,” says Grieve. “This provides us with additional significant flexibility and additional cultivation capacity.”

Ontario’s lottery system to dole out the first wave of cannabis shop licences is producing some unusual results across the province.

Canada’s most populated province will allow privately owned retail marijuana sales starting April 1, after the Ford government abandoned a plan for government-run stores last summer.

Most cannabis stocks have railed since the beginning of the year, with the average year-to-date return of our sample of 157 cannabis stocks coming in at 32.6%. However, not all stocks have been big winners. Today we have identified four Canadian cannabis stocks experiencing sharp declines year to date, which could represent an oversold opportunity.

Cannabis stocks faced a difficult outlook Thursday, mirroring US markets as a whole.

The Marijuana Index, which tracks the cannabis sector in the US and Canada, was down 2.5% to 277.4.

Buds

MYM Nutraceuticals Inc (OTCMKTS:MYMMF) (CSE:MYM) stock is doing well Thursday thanks to a new partnership with Elite Ventures Group LLC on 120 acres of CBD-rich hemp in Nevada. Based on Elite’s prior cultivation success in similar circumstances, the parcel represents potential revenue of more than $26 million, of which MYM is entitled to 50%, less sales and processing fees. Investors liked what they heard, sending the share price up nearly 10% to $0.43 on the OTC Markets and more than 7% to $0.57 on the CSE.

Last month, on the day the cabinet approved the exporting of medicinal cannabis, attorney Yair Geva got the green light for signing a deal with a foreign company, about to be listed on NASDAQ, which intends to invest in an Israeli company, the valuation of which instantly spiked.

A recreational-cannabis store poised to open in Langford this year is the latest link in a chain of Clarity Cannabis outlets founded by a Victoria pharmacist.

Michael Forbes has already launched three stores in Alberta, with another 26 awaiting construction and regulation approvals in that province.

He plans to open seven in B.C. and one in Saskatchewan.

In addition to the Langford outlet, Forbes said he intends to open stores in Cranbrook, Dawson Creek, Kamloops, Prince Rupert and two in Victoria.

“As a licensed and practicing pharmacist, I find a lot of crossover in terms of retailing cannabis and pharmaceuticals in terms of ensuring customer safety and treating everyone with compassion and fairness,” Forbes said in an email to the Times Colonist.

Since the beginning of the year, we have seen quite a bullish trend sweep through the world of marijuana stocks. Many companies have seen their values double or even triple, which is all a result of the friendly investor space on cannabis. Projections are showing that in the coming few years, marijuana is expected to grow in the billions, which means that there is a lot more opportunity waiting out there.

One of the most common places to begin investing is the industry on pure-play cannabis or those who grow the physical plant. These companies seem to be at the top of the market and continue to illustrate why they are the forefront of marijuana investing.

While cannabis is inextricably intertwined with youth culture, and parents wring their hands over fears of children getting hooked on the devil’s weed, the fastest-growing group of cannabis consumers is adults over 50.

Boomers are going back to their hippie roots as they drift into seniority on a cloud of smoke. Retirement, fewer responsibilities, more free time, no drug testing, and the onset of medical issues mean that seniors are a perfect target demographic for the drug.

Weed, marijuana, pot, cannabis, loud, Mary Jane, sticky icky, green, chronic, tea… Whatever you call it, it is a growing market in the United States. Ten or fifteen years ago you would have been laughed out of a room if you brought up the idea of legalized marijuana in the U.S. In recent years though, the trend has definitely been in that direction. Medical marijuana has been around for years, but legalized recreational marijuana is fairly new. Ten states now have voted in favor of recreational marijuana, and our northern neighbor, Canada, legalized marijuana on the national level in 2018.

The past six months have been an absolute whirlwind for the marijuana industry. In October, we witnessed the industry gain the legitimacy it's sought for so long after Canada became the first industrialized country in the world to legalize recreational cannabis. Then, just weeks later, the U.S. midterm elections increased the number of states to have given the green light to medical cannabis to 33. A month later, President Trump signed the Farm Bill into law, legalizing hemp and hemp-derived cannabidiol products. At seemingly every turn, the outlook for the cannabis industry has been improving.